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The arduous task of rationally designing small-mole-
cule enzyme inhibitors is complicated by the inherent
flexibility of the protein scaffold. To gain insight into
the changes in dynamics associated with small-
molecule-based inhibition, we have characterized,
using NMR spectroscopy, Escherichia coli dihydro-
folate reductase in complex with two drugs: metho-
trexate and trimethoprim. The complexes allowed
the intrinsic dynamic effects of drug binding to be
revealed within the context of the ‘‘closed’’ structural
ensemble. Binding of both drugs results in an iden-
tical decoupling of global motion on the micro- to
millisecond timescale. Consistent with a change in
overall dynamic character, the drugs’ perturbations
to pico- to nanosecond backbone and side-chain
methyl dynamics are also highly similar. These data
show that the inhibitors simultaneously modulate
slow concerted switching and fast motions at distal
regions of dihydrofolate reductase, providing a
dynamic link between the substrate binding site and
distal loop residues known to affect catalysis.
INTRODUCTION
Proteins adopt ensembles of conformations in solution. Although
this is often demonstrated with enzymes, the dynamic equilibria
between structural substates in either catalytic or noncatalytic
proteins have a direct impact on substrate or ligand binding,
catalysis, and product release (Boehr et al., 2006; Careri et al.,
1979; Eisenmesser et al., 2002; Frederick et al., 2007; Karplus
and McCammon, 2002; Lee et al., 2000; Watt et al., 2007; Zidek
et al., 1999). Understanding how protein dynamics influences
small-molecule binding and release should therefore greatly
enhance efficient rational drug design (Teague, 2003). Surpris-
ingly, few experimental studies have focused on the dynamical
consequences of drug inhibition. Herein we detail a structural
andmulti-timescale dynamical study of Escherichia coli dihydro-
folate reductase bound to its cofactor NADPH and to either of the
small-molecule drugs methotrexate (MTX) or trimethoprim
(TMP). NMR spectroscopy is uniquely suited to study protein386 Structure 17, 386–394, March 11, 2009 ª2009 Elsevier Ltd All ristructure and dynamics in solution with atomic resolution and
was used extensively in this report.
Dihydrofolate reductase (DHFR) is a classic drug target and
one of the most comprehensively studied enzymes (Schnell
et al., 2004b). It catalyzes the NADPH-dependent reduction of
dihydrofolate to tetrahydrofolate. Tetrahydrofolate is required
for the biosynthesis of DNA bases and key amino acids. DHFR
thus plays a vital role in cell proliferation, and is a popular target
for chemotherapeutic agents. MTX and TMP are established
antifolates against DHFR, sharing a common 2,4-diamino-
pyrimidine moiety (Figure 1A). MTX, the first successful anti-
cancer drug (Burton et al., 2006; Huennekens, 1994), not only
binds to human DHFR but also binds with low nanomolar affinity
to the E. coli enzyme (Sasso et al., 1994). TMP is an antibiotic that
specifically targets the bacterial enzyme, also binding with high
affinity (Kd = 6 pM) (Sasso et al., 1994). We sought to determine
how binding of these different drugs impacts the motions of this
functionally dynamic enzyme.
During its catalytic cycle, E. coli DHFR switches between
‘‘closed’’ and ‘‘occluded’’ conformations (Sawaya and Kraut,
1997). This global exchange is largely defined by the conforma-
tion of the Met20 loop flanking the active site (Figure 1B). In the
closed conformation, the nicotinamide moiety of NADPH is
buried within the active site. The Met20 loop packs against
the cofactor, closing the active site to solvent. The closed
conformation is partially stabilized by hydrogen-bond interac-
tions between the Met20 loop and the F-G loop (Figure 1B)
(Sawaya and Kraut, 1997). Upon hydride transfer, DHFR
undergoes a conformational switch to the occluded conforma-
tion. The Met20 loop forms a short 310 helix, projecting the side
chain of M16 into the active site, thus occluding the cofactor
binding pocket. To form the occluded conformation,
hydrogen-bond interactions between the Met20 loop and the
F-G loop are broken, and new interactions with the residues
on the G-H loop are formed (Sawaya and Kraut, 1997).
Whereas the work of Wright and colleagues have focused on
the catalytic cycle and how dynamics are modulated by the
conformation of the Met20 loop (Boehr et al., 2006; McElheny
et al., 2005; Osborne et al., 2001; Schnell et al., 2004a,
2004b), less has been reported on how inhibitors alter E. coli
DHFR dynamics. In fact, even though the same (closed) confor-
mation is present before and after dihydrofolate or drug
binding, there have been few studies of the effect of ligand
binding in the context of the closed state. Most studies haveghts reserved
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conformational change in the loops flanking the active site of
DHFR (for a review, see Schnell et al., 2004b). The study of
drug binding within the closed state allows intrinsic drug
binding effects to be separated from subsequent conforma-
tional changes.
In this paper, we present the results of a comprehensive
dynamical investigation of DHFR inhibition brought about by
small-molecule drugs. Use of MTX and TMP ligands in this
system allows for NMR-monitored dynamics to report on both
the sampling of minor semistable conformations within the
closed ensemble as well as smaller, faster motions that may
lead to those conformational excursions. Experiments sensitive
to micro- to millisecond (ms-ms) conformational dynamics indi-
cate localized regions of drug-bound DHFR experience slow
motion analogous to the reactive complex (vide infra). Moreover,
MTX and TMP alter the collective enzyme motions in exactly the
same manner: residues lining the drugs retain their ms-ms
switching, whereas distal loops stop switching altogether.
Thus, as a whole, the inhibited protein is dynamically dysfunc-
tional. Drug-bound DHFR appears to be on the brink of a global
transition, but its restricted loops prevent the transition from
occurring, leaving a ‘‘half-switching’’ enzyme. Changes in pico-
to nanosecond (ps-ns) backbone amide and side-chain methyl
dynamics indicate drug binding is ‘‘felt’’ throughout the protein.
These changes in fast dynamics show structural connectivity
to distal loops implicated in function and provide insight into
the possible linkage between fast fluctuations that may precede
or contribute to slower switching events. Our results are consis-
tent with experimental and theoretical studies that indicate long-
range coupling between the active site and distal regions of
DHFR (Hammes-Schiffer and Benkovic, 2006; Ohmae et al.,
1996; Pan et al., 2000).
Figure 1. The Structure of DHFR, Its Inhibitors, and Substrate
(A) The chemical structures of trimethoprim, methotrexate, and dihydrofolate.
(B) DHFR transitions between the closed (red; PDB ID code 1RX3) and
occluded (blue; PDB ID code 1RX5) Met20 loop conformations. This transition
involves breaking hydrogen bonds with the F-G loop and creating interactions
with the G-H loop illustrated by the red (closed) and blue (occluded) dashed
lines. Regions of the DHFR structure that do not undergo significant conforma-
tional change are rendered in gray. Methotrexate is shown in magenta and
NADPH in orange. NADPH is illustrated occupying the active site, which can
only occur in the closed conformation.Structure 17,RESULTS AND DISCUSSION
Predominance of the Closed Conformation in Solution
upon Drug Binding
Crystal structures exist for the holoenzyme (E:NADPH) and the
MTX complex (E:NADPH:MTX) (Sawaya and Kraut, 1997), but
not for the TMP complex (E:NADPH:TMP). Although the holoen-
zyme has been crystallized in both closed and occluded states
as shown in Figure 1B, recent solution NMR work shows it to
be predominantly closed in solution (Osborne et al., 2003). The
MTX complex, considered a model for DHFR’s transition state,
is also found in the closed conformation (Matthews et al.,
1977; Sawaya and Kraut, 1997). Whereas the TMP complex
has been solved for Lactobacillus casei DHFR (Polshakov
et al., 2002), the structural features of the corresponding E. coli
complex were unclear. Thus, we sought to determine the struc-
tural state of the TMP complex and detect any differences in
structure between the three complexes using NMR chemical
shifts and residual dipolar couplings (RDCs).
DHFR amide chemical shift changes are exquisitely sensitive
to ligand binding and to the active site loop conformation
(Osborne et al., 2003). Chemical shift changes in response to
MTX and TMP binding were found to be primarily proximal to
drug, thus reporting on ligand binding, with similar patterns for
the two drugs (Figure 2A). If either ternary protein complex
were to undergo a closed-occluded conformational change,
one would expect clusters of sizable chemical shift changes in
the Met20 (residues 9–23), F-G (residues 117–131), and G-H
(residues 142–149) loops (Osborne et al., 2003). In particular,
the chemical shift changes in key marker residues 121 and 149
are 10% and 20%, respectively, of the expected amount for
the occluded conformation. Although the conformational change
is not observed, we note that significant drug-dependent
Figure 2. Conformational Effects of DHFR Due to Drug Binding
(A) The combined change in 1H and 15N chemical shifts, relative to holoen-
zyme, are plotted for the MTX (red) and TMP (black) complexes. Significant
changes are indicated by filled circles.
(B) Linear correlation between 1H-15N RDC values for the drug complexes and
the holoenzyme suggests they are in the same conformation. Q factors indi-
cate that RDCs agree closely with the closed conformation. PDB ID codes
1RX3 and 1RX5 were used for the closed and occluded conformations,
respectively.386–394, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 387
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(119) in the case of MTX (Figure 2A). Although the analogous
change is not recognized as statistically significant in the TMP
complex, an obvious deviation from baseline is observed. These
data indicate the ensemble conformations of the drug-bound
complexes are nearly identical to the holoenzyme.
RDC data confirm structural homogeneity between the three
complexes. The correlation of RDCs for either drug complex is
strikingly linear with respect to the holoenzyme, indicative of
no significant conformational change (Figure 2B). This was
corroborated upon calculation of ‘‘quality factors’’ (Cornilescu
et al., 1998), Q. RDCs of either drug complex show good agree-
ment with the closed form, Q = 0.24–0.27, and poor agreement
with the occluded form, Q = 0.46–0.53 (Figure 2B). Overall, the
chemical shift and RDC data indicate the three DHFR complexes
are in the closed conformation, and that any large-scale struc-
tural differences are imperceptible. Minor changes in chemical
shift are observed in the F-G loop, suggestive of propagation
of subtle changes in local conformation and/or dynamics.
Drug-Induced Decoupling of a ms-ms Functional
Global Switch
As DHFR moves through its catalytic cycle, it undergoes slow,
ms-ms collective motions that are dependent on substrate,
product, and cofactor ligands (Boehr et al., 2006). To see how
these functional motions are modulated by drug binding, 15N
CPMG (Carr-Purcell-Meiboom-Gill) relaxation dispersion exper-
iments (Loria et al., 1999b) were carried out on the three closed
complexes. The dispersion data for all complexes were fitted to
the general equation for the two-site exchangemodel to yield the
exchange rate (kex = k1 + k1), the change in chemical shift (Du),
and populations pa and pb (Palmer et al., 2001). The residues that
show dispersion in addition to representative dispersion curves
are shown in Figure 3.
The holoenzyme was previously characterized at 281 K, with
supportive data at 284 K (Boehr et al., 2006). Our holoenzyme
data at 284 K are in agreement, showing 23 sites that yield signif-
icant R2 dispersion (data not shown). At 298 K, a total of seven
sites yielded dispersions indicative of slow switching, all within
the substrate binding region (Figure 3A). Initial fits indicate the
rate of motion to be fast (2000–4000 s1) relative to the lower
temperature (Boehr et al., 2006). Although R2 dispersion can
be extremely sensitive for detecting the sampling of minor
states, the accessible time window is relatively narrow; thus,
the reduction of sites showing significant dispersions at 298 K
may be due to a modest increase in exchange rates (Palmer
et al., 2001). Upon inspection, at 298 K, residues such as G121,
a marker for global conformational exchange (McElheny et al.,
2005; Osborne et al., 2001, 2003), indeed show slight R2 disper-
sion curvature as a result of ms motion (Figure 3). Model-free
analyses of R1, R2, and
15N-{1H} nuclear Overhauser enhance-
ment (NOE) data at 298 K provide an additional, independent
evaluation of ms-ms timescale motion within DHFR. As shown
in Figure 4A, models that account for motion on the ms-ms time-
scale (i.e., models 3 and 4 that use an Rex term) are required to
accurately fit these data for many residues in the holoenzyme,
indicating widespread presence of ms-ms conformational
exchange. Both Met20 and F-G loop residues require usage of
Rex terms. Thus, at 298 K, the holoenzyme active site and loops388 Structure 17, 386–394, March 11, 2009 ª2009 Elsevier Ltd All rigappear to be involved in functional conformational switching
(Figures 3A and 4A; see Tables S1 and S2 available online), as
observed previously (Boehr et al., 2006).
Binding of MTX and TMP to the holoenzyme at 298 K results in
10 residues exhibiting R2 dispersion in these complexes
Figure 3. R2 Relaxation Dispersion of DHFR, Holo and Bound to
Drugs
(A) Relaxation dispersion of the holoenzyme was recorded at two tempera-
tures, 284 K and 298 K. Due to the fast exchange rates, only 7 residues show
significant dispersions at the higher temperature (orange spheres). At 284 K,
the same residues were observed (orange spheres) in addition to the residues
indicated by red spheres. TheR2 dispersion profiles for G121 at 298 K (orange)
and 284 K (red) are plotted.
(B) Residues that exhibit significant R2 dispersion in MTX and TMP complexes
at 298 K only (blue and green spheres, respectively). In the case of the MTX
complex, A8 (orange sphere) also exhibited dispersion at 284 K. Conforma-
tional exchange is localized to the active site in both complexes. The fitted R2
dispersion profiles for active site residue F31 are shown (blue and green). In
stark contrast to the holoenzyme, drug bindingquenches exchange in the func-
tional loops of DHFR, as indicated by the flat dispersion profiles (black lines) of
G121 (black spheres).
Error bars represent standard deviations estimated from duplicate relaxation
time points.hts reserved
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Dynamic Dysfunction in Dihydrofolate ReductaseFigure 4. The ‘‘Model-Free’’ Dynamic Response of DHFR to Drug Binding
(A) Model selection results for E:NADPH, E:NADPH:MTX, and E:NADPH:TMP. Structures are colored as follows (models 1–5): S2 only in blue; S2 and te in cyan; S
2
and Rex in yellow; S
2, Rex, and te in green; and S
2
f, S
2
s, and te in red. Residues that did not fit to a model are in orange, and residues that could not be fit due to
spectral overlap are in gray.
(B) The change in backbone order parameter due to MTX (red) and TMP (black) binding to the holoenzyme. Residues that experience consensus significant
change are indicated by filled circles. G121 (blue fill) shows a dynamic response in the MTX complex. Residues 67–69 (green stippling) exhibit a consistent, slight
increase in rigidity. Error bars represent propagated standard deviations derived from Monte Carlo simulations. The inset shows the correlation in the dynamic
responses of DHFR (relative to holoenzyme) to binding both drugs.(Figure 3B; Table S1). These sets of residues are nearly identical
(8, 9, 28, 29, 30, 31, 111, and 112 in both), cluster around the
substrate/drug binding site, and exhibit similar switching. The
global kex rates are indistinguishable at 430 ± 150 s
1 and
460 ± 170 s1 for MTX and TMP, respectively, with both excited
state populations at 2%. Thus, MTX and TMP binding result in
the same collective slow motion in DHFR, albeit slower than in
the holoenzyme. To test whether fast microsecond motions are
present but difficult to detect at 298 K, R2 dispersion curves
were collected for the MTX ternary complex at 284 K. In stark
contrast to the holoenzyme, only one residue (A8) exhibited
significant R2 dispersion, indicating that much of the dynamics
of the ternary complex is indeed quenched by drug
(Figure 3B). It is striking that binding either drug leads to
complete loss of R2 dispersion in the F-G and G-H loops, while
retaining slow motions around the substrate binding site
(Figure 3). At 298 K, considering all indicators of slow motion
(i.e., from R2 dispersion and model-free analysis), the holoen-
zyme shows 47 sites experiencing microsecond motion, and
theMTX and TMP complexes show 18 and 23 sites experiencing
ms-ms motion, respectively (Tables S1–S4).
It should be mentioned that the E:NADP+:folate complex has
been used as amodel for the closed, reactiveMichaelis complex
(McElheny et al., 2005). In this complex, the substrate binding
and loop regions undergo conformational change, apparently
in a concerted, global, closed-occluded conformational
exchange, characterized by kex = 477 s
1 (reported at 303.4 K),
although the observed structural change is manifested primarily
in the loops and not the substrate binding pocket (Sawaya and
Kraut, 1997). The calculated forward closed-to-occluded rateStructure 17, 3of the E:NADP+:folate complex at 298 K is 11 s1 (McElheny
et al., 2005), which, coincidentally, matches the product release
rate (Boehr et al., 2006). From our drug complex data, the
forward ground-to-excited rates of the substrate binding resi-
dues (see above) in the closed ternary drug complexes (at
298 K) are similarly calculated to be 7.4 ± 2.7 s1 and 10.6 ±
3.8 s1 for MTX and TMP complexes, respectively. Because
these sites show the same forward rate as for the corresponding
region in the also-closed E:NADP+:folate complex, this suggests
that drug binding initiates similar ‘‘micro-switching’’ in the
substrate binding pocket to that which occurs in the global
closed-to-occluded transition. It has recently been proposed
that the closed-occluded conformational change is an intrinsic
feature of the E. coli DHFR structure (Schnell et al., 2004b).
Although it is not clear whether a true closed-to-occluded transi-
tion is occurring in the holoenzyme (Boehr et al., 2006) or at least
partially in the substrate binding pockets of the closed drug
complexes, it is evident that drug binding slows down motion
in the binding pocket and removes functional loop conforma-
tional changes.
Taking these data together, we conclude that in these two
drug complexes a dynamic decoupling occurs. The active site
(substrate binding pocket) behaves as though the enzyme is
poised to undergo the global transition that it has evolved to
make, but MTX and TMPmanage to dampen and slow the larger
concerted motion, probably via formation of stable contacts with
the nicotinamide moiety or protein (Sawaya and Kraut, 1997). In
effect, the enzyme is ‘‘in a dynamic straightjacket’’ and the loops
cannot perform conformational switching, even though the
active site is initiating ms-ms timescale switching events. Thus,86–394, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 389
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motions, which are present in every physiological complex
(Boehr et al., 2006), have been decoupled by binding either
MTX or TMP.We propose that filling the active site sends a signal
through the enzyme to initiate conformational change, but these
complexes are locked in the closed conformation and therefore
the signal becomes ineffective, resulting in a dysfunctional, half-
switching enzyme (Figures 3 and 4A).
Consensus Drug Binding Effects on ps-ns Motions:
Pretransitional Connectivity to Distal Loops
that Regulate DHFR Activity
To expand the timescale range of the effects that MTX and TMP
binding have on DHFR dynamics, 15N dipolar and methyl 2H
quadrupolar relaxation experiments were carried out on all three
complexes to characterize backbone and side-chain ps-ns
dynamics at 298 K. The relaxation data were interpreted in terms
of the Lipari-Szabo ‘‘model-free’’ formalism, in which the
squared generalized order parameter indicates the motional
restriction of the backbone N-H bond (S2) or, in the case of
side-chain methyl groups, the methyl symmetry axis (S2axis)
(Lipari and Szabo, 1982). The order parameter can range
between 0and1, corresponding to complete disorder and a fixed
orientation in the molecular frame, respectively. Because the
observed ms-ms dynamics are between a highly populated
ground state and a lowly populated excited state, the relaxation
rates have negligible contribution from the excited state and
therefore report on conformational fluctuations (i.e., dynamics)
within the closed, ground state of each complex. In principle,
isolating motion within the ground-state ensemble may allow
identification of key, pretransitional, motions that facilitate larger,
slower conformational changes, thus potentially enabling study
of both cause and effect (of a conformational change). To the
extent that MTX (or even TMP) mimics the closed transition state
along the reaction coordinate (Sawaya and Kraut, 1997), the fluc-
tuations will correspond to motions promoting conformational
changes associated with reactivity (Agarwal et al., 2002).
Backbone Dynamics
Backbone amide order parameters (S2) were extracted from 15N
R1, R2, and
15N-{1H} NOE data collected at two fields. Model
selection was carried out using global anisotropic tumbling (see
Experimental Procedures) and yielded quite different models for
the holoenzyme versus ternary drug complexes (Figure 4A).
Specifically, model 3 (S2, Rex) was selected for a large number
of residues in the holoenzyme, indicating widespread ms-ms
motion, in contrast with significantly fewer residues in the drug
complexes (see discussion above). In addition, model 5 (S2f,
S2s, ts), as well as complex motions that did not fit well to any
model,was frequently required in theF-G loopof theholoenzyme,
with few complex motions detected in the ternary complexes.
Thus, drug binding simplifies the motional landscape of the holo-
enzyme over a wide timescale range.
The model-selected backbone order parameters were found
to reflect consistent dynamic changes upon binding MTX and
TMP. Although overall backbone flexibility is similar for the three
complexes, clear changes in order parameters (DS2) emerge for
specific residues in response to binding (Figure 4B). These
changes follow similar trends for the two drugs, with r = 0.74
(see Figure 4B, insert). Because of the high quality of these390 Structure 17, 386–394, March 11, 2009 ª2009 Elsevier Ltd All rdata, we set a criterion for consensus changes in dynamics: resi-
dues that showed significant change in S2 (R23 error), in the
same direction, upon binding either drug. These consensus resi-
dues are 33, 51, 73, 134, and 159 (Figure 4B). In addition, the
adenosine binding loop residues 67–69 are individually noisy,
but collectively show average rigidification of about 0.05 in
response to drug binding. These consensus changes in back-
bone dynamics impart high confidence in altered flexibility
observed at sites that extend far beyond the substrate binding
site. Finally, although it does not respond to TMP, the catalyti-
cally important and distal residue G121 (in the F-G loop)
undergoes an increase in flexibility (by 0.06) in response to
MTX binding (Figure 4B), 15 A˚ away.
Side-Chain Dynamics
Side-chain methyl order parameters (S2axis) are exquisitely
sensitive probes to dynamic changes as a result of ligand binding
(Fuentes et al., 2004; Lee et al., 2000) and complement the back-
bone dynamics by increasing coverage. As shown in Figure 5,
methyl side chains are evenly distributed in both the catalytic
and adenosine binding subdomains of DHFR, providing a
uniform probe of dynamics. The changes in S2axis indicate
DHFR methyl groups generally become more rigid on the
ps-ns timescale (Figure 5; Figure S4), and the MTX- and TMP-
induced changes are correlated (r = 0.65). As expected, residues
making contact with drug show the largest changes. Interest-
ingly, residues 60–62 in the adenosine binding domain display
significant changes in S2axis in both ternary drug complexes.
Drug binding rigidifies I60d1 and L62d2, whereas I61d1 becomes
more flexible (Figure S4). Although these residues are outside
the substrate binding pocket, they are conserved in DHFR, are
prominent in a statistical coupling analysis (SCA) -based
network, and may be involved in promoting catalysis (Chen
et al., 2007). Spatially, they also lie in between the substrate
binding site and loop residues 67–69. The changes in S2axis
Figure 5. Distribution of Methyl-Bearing Side Chains in DHFR
Methyl sites within DHFR are represented by the colored spheres. Residues
that show significant change in order parameter (R 23 error) as a result of
binding (A) MTX or (B) TMP to the holoenzyme are shown in red. Residues
that do not change are represented by green spheres. Methyl sites that were
not comparable due to spectral overlap in the drug bound and/or holo enzyme
are colored gray. The ligands MTX, TMP, and NADPH are shown in magenta,
cyan, and yellow, respectively.ights reserved
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binding subdomain is dynamically linked to the substrate binding
pocket. Of special note, the dynamics of M203 is very different
between MTX and TMP complexes (0.20 versus 0.50;
Figure S4), although the methyl resonance was overlapped in
the holoenzyme. Thus, the dynamics of M20 is clearly perturbed
upon binding one or both drugs.
The significant changes in side-chain and backbone ps-ns
order parameters are summarized in Figure 6. It is clear that local
perturbation by small molecules has far-reaching dynamic
consequences in this enzyme on the ps-ns timescale. Drug
binding induces ps-ns dynamics changes in residues 50, 51,
60, 61, 62, and 73, which essentially form a pathway to the
base of the loop containing the perturbed G67 (Figure 6). Simi-
larly, dynamics and subtle chemical shift changes are observed
in the F-G loop, in particular, upon MTX binding. These findings
complement reports that demonstrate distal regions of DHFR to
be linked to catalysis: mutation of either G121 (F-G loop) or G67
(adenosine binding loop) has significant effects on kcat/KM
(Cameron and Benkovic, 1997; Gekko et al., 1994; Ohmae
et al., 1996). Furthermore, G121 and G67 have been shown to
be thermodynamically coupled with each other with respect to
kcat (Ohmae et al., 1998), despite their physical separation by
28 A˚; and theoretical studies suggest these residues are corre-
lated to the active site (Agarwal et al., 2002; Pan et al., 2000; Rad-
kiewicz and Brooks, 2000). Our experimental data demonstrate
a direct dynamic connectivity, within the confines of the closed
ensemble, between the active site and functional distal regions
in DHFR. This supports the idea that dynamics provides a mech-
anism for propagating functional change observed upon muta-
tion or ligand binding. Indeed, previous NMR studies have shown
that changes in ps-ns side-chain dynamics can reveal propaga-
tion pathways linking distal sites (Clarkson and Lee, 2004;
Fuentes et al., 2004), and in some cases, linking distal functional
sites (Igumenova et al., 2005; Namanja et al., 2007).
It is important to emphasize a key difference between the
ps-ns dynamics comparison made here and in previous studies
(Osborne et al., 2001; Schnell et al., 2004a). In those studies,
dynamics changed in response to a change in the Met20 loop
conformation. By contrast, here, alterations in ps-ns dynamics
is a direct result of ligand binding in the absence of conforma-
tional change. Because the binding of antifolates such as MTX
and TMP appears to be the only way to study substrate binding
effects (by NMR) without inducing a net conformational change,
such small molecules can be important tools for isolating pure
dynamic changes within the closed state, and potentially for
capturing motions that trigger—or quench, depending on how
one perceives the reference state—larger, slower dynamic
events. From our data, we can speculate that because the
ps-ns motions of G121 are sensitive to ligand occupancy in the
context of the closed state, these results are consistent with
G121, and perhaps its nearest neighbors, participating in rapid,
pretransitional, initiating movements to the occluded conforma-
tion (Chen et al., 2007; Radkiewicz and Brooks, 2000).
Sensitivity of Closed Conformational Dynamics
to Ligand Structure
Depending on ligand occupancy in its two binding sites, DHFR
undergoes different ms-ms switching dynamics (Boehr et al.,Structure 17, 32006). The data here show that the high-affinity drugs MTX and
TMP cause novel half-switching behavior on the ms-ms time-
scale, with additional perturbations to ps-ns fluctuations.
Whereas the Met20 loop conformation is clearly an important
factor in regulating DHFR dynamics (Osborne et al., 2001;
Schnell et al., 2004a), we propose that, even with a fixed
Met20 loop conformation, motion across a wide range of time-
scales can be regulated by the specific nature of ligands bound.
Occupation of the active site by small ligands of different shapes
Figure 6. Summary of ps-ns Dynamic Changes
The dynamic responses as a result of binding MTX or TMP are illustrated in (A)
and (B), respectively. Residues with significant change in backbone amide
(blue) and side-chain methyl (red) order parameter (complex, E:NADPH) are
mapped onto the DHFR structure. Residues 67–69 are highlighted in green.
The ligands MTX, TMP, and NADPH are shown in magenta, cyan, and yellow,
respectively.86–394, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 391
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enzyme, resulting in differential thermal fluctuations that propa-
gate through the structure. In this view, enzymes, through evolu-
tion, develop sensitivities to ligand properties from which mech-
anisms for organizing and building such fluctuations into useful
work can arise. The collective results on DHFR dynamics
support the notion of a so-called allosteric wiring network that
connects distal regions of the protein (Chen et al., 2007;
Hammes-Schiffer and Benkovic, 2006). It has been suggested
that coordinated motions within the network are responsible
for controlling the large conformational transition (Chen et al.,
2007) and the chemical step of catalysis (Agarwal et al., 2002)
in DHFR. Binding MTX or TMP may disrupt these motions and
reduce connectivity within the network, preventing the transition
from occurring.
Concluding Remarks
In this report, we have presented a dynamic survey of DHFRwith
reduced cofactor in the presence and absence of two potent
inhibitory drugs, methotrexate (MTX) and trimethoprim (TMP).
Binding either drug results in essentially identical behavior:
quenched ms-ms conformational exchange in the Met20, F-G,
and G-H loops, and slowed substrate binding site ms-ms
dynamics. MTX and TMP partially suppress the global confor-
mational switching that is found in every physiological complex
(Boehr et al., 2006); however, this suppression takes place within
the closed conformational ensemble. On the ps-ns timescale,
both backbone amides and methyl side chains show sparse,
yet largely consistent changes in their dynamics as a result of
drug binding. The changes in these fast motions show that,
despite a lack of overall conformational change, changes prop-
agate to the distal F-G and adenosine binding loops that contain
residues implicated in DHFR function. The emergent picture is
that upon binding high-affinity drug, the enzyme is on the brink
of a structural transition yet trapped in the closed conformation.
It is left undergoing slow, correlated switching in the substrate
binding site. Because the affected loop structures are primarily
not in contact with drug, it is reasonable to envision inhibitory
small-molecule drugs that act by allosterically modulating
dynamic motions.
EXPERIMENTAL PROCEDURES
Protein Purification
DHFR was expressed in M9 minimal media supplemented with combinations
of 15NH4Cl, D-glucose (U-
13C6-99%), and
2H2O. The cells were harvested by
centrifugation and suspended in lysis buffer (20 mM sodium phosphate,
50 mM sodium chloride, 1 mM EDTA, 1 mM DTT [pH 6.8]). DHFR was purified
usingmethods similar to those previously described (Rajagopalan et al., 2002).
Cell lysate was loaded onto an MTX affinity column (Sigma). The column was
washed with lysis buffer containing 750 mMNaCl, and protein was eluted with
buffer containing 20 mM sodium borate, 750 mM NaCl, 1 mM EDTA, 1 mM
DTT, 5 mM folate (pH 9.0). The eluent was passed over a G-50 gel-filtration
column (GE Biosciences) equilibrated with KPE (50mMpotassium phosphate,
150 mM KCl, 1 mM EDTA, 1 mM DTT [pH 6.8]). Any remaining folate was
removed by dialysis against KPE containing 5 M deionized urea. Finally,
DHFR was passed over a G-50 column equilibrated with NMR buffer (70 mM
HEPES, 20 mM KCl, 1 mM EDTA, 1 mM DTT [pH 7.6]). Pure DHFR was con-
centrated, lyophilized, and stored at 4C. Sample purity was estimated by
SDS-PAGE and verified by ESI-MS to be greater than 97%.392 Structure 17, 386–394, March 11, 2009 ª2009 Elsevier Ltd All rigNMR Samples
NMR experiments were performed on 1 mM DHFR in NMR buffer containing
15 mM NADPH, 10 mM glucose-6-phosphate, 10 U glucose-6-phosphate
dehydrogenase and, when applicable, 3–5 mM MTX or 2–3 mM TMP. The
protein was placed in amber NMR tubes and flame-sealed under argon.
NMR Spectroscopy
All NMR experiments were conducted at 298 K or 284 K on Varian spectrom-
eters equipped with room-temperature (500 and 600 MHz) or cryogenic
probes (700 MHz). Backbone and side-chain resonances were assigned using
standard triple-resonancemethods. NMRdata were processedwith NMRPipe
(Delaglio et al., 1995) and visualized with NMRDraw and NMRView (Johnson
and Blevins, 1994). Combined chemical shifts for the purposes of chemical
shift mapping were calculated using the Euclidean distance (Schumann
et al., 2007). Significant changes in combined chemical shift were identified
using the boxplot function in Matlab R2006b (Mathworks).
Relaxation dispersion measurements were performed at 500, 600, and
700 MHz using relaxation-compensated CPMG experiments (Loria et al.,
1999a). The total CPMGperiodwas 40ms in all experiments. The effective field
strength was modulated by changing the delay time, t. Sixteen HSQC-type
spectra composed of 13 t values between 0.556 and 10 ms, two duplicates,
and a reference experiment were collected interleaved. Peak intensities
were extracted using the NMRDraw module nlinLS. Effective R2 rates were
calculated as described (Mulder et al., 2001). Highly deuterated DHFR was
used for measuring E:NADPH and E:NADPH:MTX relaxation dispersion
whereas protonated DHFR was used for E:NADPH:TMP.
Standard backbone relaxation experiments were used to collect the R1, R2,
and {1H}-15NNOEdata at 500 and 600MHz (Farrow et al., 1994). Side-chain 2H
Dz and Dy relaxation experiments (Millet et al., 2002) were collected using mul-
ticoherence relaxation pulse sequences, similar to previously described
(Fuentes et al., 2004).
Relaxation Analysis
Motions occurring on the ms-ms timescale were characterized assuming
a two-state model. Only residues for which R2,eff changed >2 s
1 over the
series of time points were considered for further analysis. The data were
best-fitted to amodel assuming no exchange (R2 =R2
o) and a simple two-state
model. An F-test (a critical = 0.01) was used to identify residues with statisti-
cally significant exchange. To determine exchange kinetics, effective R2 rates
as a function of t1 at two fields were fit simultaneously to the Carver-Richards
equation (Palmer et al., 2001) using the in-house program exrate2.0 (by
R.V.M.). The errors in fitted parameters were estimated using Monte Carlo
simulation. Relaxation dispersion data often report on a global exchange
process and can be fitted using shared kex and pa values. To identify these
residues, we followed the procedure outlined by Kay and coworkers (Mulder
et al., 2001). As previously described, residues 129–134 and 155–159 in
E. coli DHFR report on ligand-independent exchange (Boehr et al., 2006).
These residues were not included in any global fit and were not considered
in this study.
Motions on the ps-ns timescale were characterized using the model-free
formalism (Lipari and Szabo, 1982). Using the strategy outlined by Dellwo
and Wand (1989), the isotropic rotational correlation times for the binary and
ternary complexes were determined to be 11.2 and 10.5 ns/rad, respectively.
Although the ternary correlation times are shorter than the binary, the effect is
small and could be explained by deviation from isotropic tumbling, a change in
hydration patterns around the active site, or a small degree of nonspecific
aggregation in the binary complex. Rotational diffusion anisotropy was calcu-
lated via the local Di method (Lee et al., 1997) using the in-house program qfit
and Protein Data Bank (PDB) ID code 1RX3. The values of Dk/Dt for the
E:NADPH, E:NADPH:MTX, and E:NADPH:TMP complexes are 1.15, 1.18,
and 1.14, respectively. Rotational anisotropy has been shown to have a large
impact on backbone model selection and was used in the subsequent anal-
yses (Osborne and Wright, 2001). Backbone relaxation rates were fitted to
the five ‘‘model-free’’ models using the in-house program relxn2.2 (Clarkson
et al., 2006; Lee et al., 1999). The values used for the effective N-H bond
distance and the 15N chemical shift anisotropy were 1.02 A˚ and 170 ppm,
respectively. Akaike’s information criterion was used to select the model
that best describes the motion (d’Auvergne and Gooley, 2003). Side-chainhts reserved
Structure
Dynamic Dysfunction in Dihydrofolate Reductasemethyl dynamics parameters were carried out as described previously
(Fuentes et al., 2004). The quadrupolar coupling constant was set to
165 kHz (Muhandiram et al., 1995).
Residual Dipolar Coupling
DHFRwas partially aligned using a 6mm stretched gel alignment kit (6% acryl-
amide) (Chou et al., 2001). Crosspeak positions of isotropic and anisotropic
IPAP-HSQC spectra were adjusted and fitted using the ipap.tcl and nlinLS
modules provided in NMRPipe. The 1DHN value was calculated by subtracting
the measured coupling in the isotropic experiment from the anisotropic exper-
iment. PDB ID codes 1RX3 (closed) and 1RX5 (occluded) were used to calcu-
late Q factors (Cornilescu et al., 1998). The data were analyzed using the
program REDCAT (Valafar and Prestegard, 2004).
SUPPLEMENTAL DATA
Supplemental Data include four figures and four tables and can be found with
this article online at http://www.cell.com/structure/supplemental/S0969-2126
(09)00067-7.
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